Join
Live feed
·
NEWSReleasevia Quantisnow
Cosmos Health Inc. logo

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

ByQuantisnow·Wall Street's wire, on your screen.
COSM· Cosmos Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COSM (Cosmos Health Inc.) and more on Quantisnow.